Brucellosis Vaccine(Live) (Lanzhou Institute Of Biological Products)

布氏菌活疫苗（兰州生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBrucellosis Vaccine(Live) (Lanzhou Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Live attenuated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBrucellosis

Global Approved IndicationsBrucellosis

Approved Indications in ChinaBrucellosis

Original Approved Country/TerritoryMainland China

Original Approved Date1982/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsBrucellosis

Inactive IndicationsN/A

Other Information

ATC CodeJ07AD